Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Project Finance topic

No spam. Unsubscribe anytime.

Study: Tolles Garden project shows $3.1M funding gap; TIF NPV roughly equals shortfall

Fort Myers Community Redevelopment Agency Board of Commissioners · October 1, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The advisory-board packet included a needs analysis and economic-impact study estimating a roughly $3.11M funding deficit for the Tolles Garden 141-unit project; projected TIF rebate cash flows (net present value) are roughly $3.0M, a figure staff and developers said would help close the gap.

Maxwell, Hendry & Simmons analyst Matt Simmons presented the advisory board with the project’s needs-analysis highlights and an economic-impact estimate.

Simmons said construction-phase activity is expected to support about 310 jobs and the combined construction and first-seven-year operations impact is about $88.5 million. He told the board hard costs average about $256,000 per unit and that projected net sales proceeds are roughly $33.0 million; total development costs were presented as about $53.4 million, yielding a deficit of approximately $3.11 million.

On the revenue side, Simmons said the sum of annual TIF rebate payments available to the project is just under $5.7 million and that, when discounted over an 18-year payout at a 6.5% rate, the net present value of that stream is just over $3.0 million—near the funding shortfall. "The sum of payments essentially that are available for rebate is just under 5,700,000," he told the board, and later: "the net present value is just a touch over 3,000,000."

Simmons and the developer explained the TIF rebate would be paid out over time (not a lump sum) and that the larger capital stack includes private equity, construction financing and the pending CDBG-DR grant. Board members asked about cost-benchmarking and the analyst said cost estimates were validated with third-party benchmarks and cost quotes.